Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report

Abstract Background Recent advance of genetic testing has contributed to the diagnosis of hereditary pheochromocytoma and paraganglioma (PPGL). The clinical characteristics of hereditary PPGL are varying among the types of mutational genes. It is still difficult to specify the pathognomonic symptoms...

Full description

Saved in:
Bibliographic Details
Main Authors: Masahiro Shibata, Takahiro Inaishi, Noriyuki Miyajima, Yayoi Adachi, Yuko Takano, Kenichi Nakanishi, Dai Takeuchi, Sumiyo Noda, Yuichi Aita, Kazuhiro Takekoshi, Yasuhiro Kodera, Toyone Kikumori
Format: Article
Language:English
Published: Japan Surgical Society 2017-12-01
Series:Surgical Case Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40792-017-0408-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850045376294289408
author Masahiro Shibata
Takahiro Inaishi
Noriyuki Miyajima
Yayoi Adachi
Yuko Takano
Kenichi Nakanishi
Dai Takeuchi
Sumiyo Noda
Yuichi Aita
Kazuhiro Takekoshi
Yasuhiro Kodera
Toyone Kikumori
author_facet Masahiro Shibata
Takahiro Inaishi
Noriyuki Miyajima
Yayoi Adachi
Yuko Takano
Kenichi Nakanishi
Dai Takeuchi
Sumiyo Noda
Yuichi Aita
Kazuhiro Takekoshi
Yasuhiro Kodera
Toyone Kikumori
author_sort Masahiro Shibata
collection DOAJ
description Abstract Background Recent advance of genetic testing has contributed to the diagnosis of hereditary pheochromocytoma and paraganglioma (PPGL). The clinical characteristics of hereditary PPGL are varying among the types of mutational genes. It is still difficult to specify the pathognomonic symptoms in the case of rare genetic mutations. Here, we report the case of synchronous bilateral pheochromocytomas and paraganglioma with novel MYC associated factor X (MAX) gene mutation. Case presentation A 24-year-old female had hyperhidrosis and hypertension. Her urine test showed high normetanephrine and vanillylmandelic acid. Enhanced computed tomography revealed three enhanced masses in right adrenal gland, left adrenal gland, and left renal hilus. She was diagnosed with PPGL. Because 123I-metaiodobenzylguanidine scintigraphy indicated the accumulations in the left adrenal gland mass and the left renal hilus mass and not in the right adrenal gland mass, we performed laparoscopic left adrenalectomy and extirpation of the left renal hilus mass to preserve the right adrenocortical function. However, her symptoms recurred shortly after the operation presumably due to unveiling of the activity of the right pheochromocytoma. Following right adrenalectomy as the second operation, the catecholamine levels declined to normal range. Her genetic testing indicated the novel germline mutation in MAX gene (c.70_73 del AAAC/p.Lys24fs*40). Conclusions MAX germline mutation is recently identified as a rare cause of hereditary PPGL. The deletion mutation in MAX gene in this patient has never reported before. In the case of bilateral pheochromocytomas, the surgical indication should be decided considering each patient’s genetic background. Due to the possibility for other types of malignant tumors, close follow-up is essential for MAX mutation carriers.
format Article
id doaj-art-c701c7ebcf2c4ba1806bfffac5c3ae6b
institution DOAJ
issn 2198-7793
language English
publishDate 2017-12-01
publisher Japan Surgical Society
record_format Article
series Surgical Case Reports
spelling doaj-art-c701c7ebcf2c4ba1806bfffac5c3ae6b2025-08-20T02:54:42ZengJapan Surgical SocietySurgical Case Reports2198-77932017-12-01311510.1186/s40792-017-0408-xSynchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case reportMasahiro Shibata0Takahiro Inaishi1Noriyuki Miyajima2Yayoi Adachi3Yuko Takano4Kenichi Nakanishi5Dai Takeuchi6Sumiyo Noda7Yuichi Aita8Kazuhiro Takekoshi9Yasuhiro Kodera10Toyone Kikumori11Department of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineFaculty of Medicine, Division of Sports Science/Laboratory Medicine, University of TsukubaFaculty of Medicine, Division of Sports Science/Laboratory Medicine, University of TsukubaDepartment of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of MedicineDepartment of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of MedicineAbstract Background Recent advance of genetic testing has contributed to the diagnosis of hereditary pheochromocytoma and paraganglioma (PPGL). The clinical characteristics of hereditary PPGL are varying among the types of mutational genes. It is still difficult to specify the pathognomonic symptoms in the case of rare genetic mutations. Here, we report the case of synchronous bilateral pheochromocytomas and paraganglioma with novel MYC associated factor X (MAX) gene mutation. Case presentation A 24-year-old female had hyperhidrosis and hypertension. Her urine test showed high normetanephrine and vanillylmandelic acid. Enhanced computed tomography revealed three enhanced masses in right adrenal gland, left adrenal gland, and left renal hilus. She was diagnosed with PPGL. Because 123I-metaiodobenzylguanidine scintigraphy indicated the accumulations in the left adrenal gland mass and the left renal hilus mass and not in the right adrenal gland mass, we performed laparoscopic left adrenalectomy and extirpation of the left renal hilus mass to preserve the right adrenocortical function. However, her symptoms recurred shortly after the operation presumably due to unveiling of the activity of the right pheochromocytoma. Following right adrenalectomy as the second operation, the catecholamine levels declined to normal range. Her genetic testing indicated the novel germline mutation in MAX gene (c.70_73 del AAAC/p.Lys24fs*40). Conclusions MAX germline mutation is recently identified as a rare cause of hereditary PPGL. The deletion mutation in MAX gene in this patient has never reported before. In the case of bilateral pheochromocytomas, the surgical indication should be decided considering each patient’s genetic background. Due to the possibility for other types of malignant tumors, close follow-up is essential for MAX mutation carriers.http://link.springer.com/article/10.1186/s40792-017-0408-xPheochromocytomaParagangliomaMAX mutation
spellingShingle Masahiro Shibata
Takahiro Inaishi
Noriyuki Miyajima
Yayoi Adachi
Yuko Takano
Kenichi Nakanishi
Dai Takeuchi
Sumiyo Noda
Yuichi Aita
Kazuhiro Takekoshi
Yasuhiro Kodera
Toyone Kikumori
Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
Surgical Case Reports
Pheochromocytoma
Paraganglioma
MAX mutation
title Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
title_full Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
title_fullStr Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
title_full_unstemmed Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
title_short Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
title_sort synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in max a case report
topic Pheochromocytoma
Paraganglioma
MAX mutation
url http://link.springer.com/article/10.1186/s40792-017-0408-x
work_keys_str_mv AT masahiroshibata synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT takahiroinaishi synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT noriyukimiyajima synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT yayoiadachi synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT yukotakano synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT kenichinakanishi synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT daitakeuchi synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT sumiyonoda synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT yuichiaita synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT kazuhirotakekoshi synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT yasuhirokodera synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport
AT toyonekikumori synchronousbilateralpheochromocytomasandparagangliomawithnovelgermlinemutationinmaxacasereport